May 29 |
Vir Biotechnology names Mark Eisner as chief medical officer
|
May 29 |
Vir Biotechnology Appoints Mark Eisner, M.D., M.P.H. as Chief Medical Officer
|
May 23 |
Vir Biotechnology to Host 2024 Annual Meeting of Stockholders
|
May 22 |
Multiple Abstracts Highlighting Vir Biotechnology’s Latest Hepatitis Delta & B Data Accepted for Presentation at the EASL Congress 2024
|
May 21 |
Vir Biotechnology Announces SOLSTICE Data to be Featured as an Oral Presentation at the European Association for the Study of the Liver (EASL) Congress 2024
|
May 8 |
Analysts Just Shipped A Stunning Upgrade To Their Vir Biotechnology, Inc. (NASDAQ:VIR) Estimates
|
May 7 |
Wall Street Analysts Think Vir Biotechnology (VIR) Could Surge 188.65%: Read This Before Placing a Bet
|
May 3 |
Vir Biotechnology, Inc. (NASDAQ:VIR) Q1 2024 Earnings Call Transcript
|
May 3 |
Vir Biotechnology Provides Some Hope For Its Beleaguered Shareholders
|
May 3 |
Q1 2024 Vir Biotechnology Inc Earnings Call
|